Aug 30, 2023 8:30am EDT Veru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023
Aug 03, 2023 8:30am EDT Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023
Jun 21, 2023 8:30am EDT Veru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants
Jun 01, 2023 8:30am EDT Veru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Board
May 04, 2023 8:30am EDT Veru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDS
May 03, 2023 8:30am EDT Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital